Shitanshu Uppal
GYOEDU Resident: Recurrent Ovarian Cancer
Management of STIC in Patients Undergoing RRSO
Publications Update # 80
Finding time to exercise, Management of STIC, NADINA trial in advanced melanoma, Final OS Keynote A-18, and overtreatment of locally advanced cervical cancer treatment prior to OUTBACK publication
Ovarian Borderline Tumors
GYOEDU Resident: Ovarian Cancer Surveillance and Recurrences
Publications Update # 79
Strategies to overcome workaholism, prevent surgical site infections, and conduct the STOP-IT trial and BALANCE trial to reduce antibiotic duration.
PAOLA-1: Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer (Overall Survival)
Olaparib combined with bevacizumab provided a OS benefit for HRD-positive ovarian cancer patients.
GYOEDU Resident: BRCA, Genetics and Parp Inhibitors
PARP Trials List
Open source article to read for reference
Leadership Styles
As a new attending or a fellow supervising a team